Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Local Iloprost for Proximal Humeral Fracture Healing
DRKS00027081Phase 2Active, not recruiting
- Sponsor
- Charité – Universitätsmedizin Berlin
- Start
- Nov 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of iloprost in proximal humerus fracture (PHF) (3 arms), sponsored by Charité – Universitätsmedizin Berlin. Started Nov 2021; status: active, not recruiting.
02
Drugs
iloprost
03
Conditions
proximal humerus fracture (PHF)
Beyond the preview
Go deeper on DRKS00027081.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00027081.